Los Angeles Classification for Distal Esophagitis
The Los Angeles (LA) classification is the standard grading system for GERD-related erosive esophagitis, defining four grades (A-D) based on the extent of mucosal breaks, with Grade B or higher constituting confirmatory evidence of erosive reflux disease requiring specific management strategies. 1, 2
Classification System
The LA classification grades erosive esophagitis based on mucosal breaks (defined as areas of slough or erythema with sharp demarcation from adjacent mucosa):
- Grade A: One or more mucosal breaks ≤5mm that do not extend between the tops of two mucosal folds 3
- Grade B: One or more mucosal breaks >5mm that do not extend between the tops of two mucosal folds 3
- Grade C: Mucosal breaks extending between the tops of two or more mucosal folds but involving <75% of the esophageal circumference 3
- Grade D: Mucosal breaks involving ≥75% of the esophageal circumference 3
Clinical Significance by Grade
Grade A (Borderline Disease)
- Not considered confirmatory evidence of erosive reflux disease - can be seen in healthy asymptomatic volunteers 1, 2
- Only 17.6% of patients with Grade A have objective GERD on pH monitoring 2
Grade B or Higher (Confirmed GERD)
- Constitutes conclusive objective evidence of erosive reflux disease 1, 2
- 100% of patients with Grade B or higher have objective GERD on pH monitoring 2
Grades C and D (Severe Disease)
- Represent severe erosive disease requiring either continuous long-term PPI therapy or consideration of anti-reflux intervention 2, 3
- Require follow-up endoscopy after treatment to document healing and exclude underlying malignancy or Barrett's esophagus 1, 4
Management Algorithm by Grade
Grade A Management
- Optimize PPI therapy rather than committing to lifelong daily therapy 2
- Implement aggressive lifestyle modifications including weight management 2
- Consider cognitive behavioral therapy or gut-directed hypnotherapy as adjunctive measures 2
- If symptoms remain controlled after optimization, wean to lowest effective dose and consider on-demand therapy with H2 blockers or antacids 2
- Critical pitfall: Avoid automatically committing patients to lifelong daily PPI therapy, as Grade A represents borderline disease 2
- If incomplete PPI response, perform prolonged wireless pH monitoring off PPI to determine if true pathologic acid exposure exists 2
Grade B Management
- Provide 4-8 week trial of single-dose PPI therapy 1, 3
- With inadequate response, increase to twice daily dosing or switch to more effective acid suppressive agent 1
- When adequate response achieved, taper PPI to lowest effective dose 1
- Consider anti-reflux intervention for chronic maintenance if erosive disease persists 3
Grades C and D Management
- Require continuous long-term PPI therapy or invasive anti-reflux procedures 2, 3
- Treat with double-dose PPIs (twice daily) for 8-12 weeks 4
- Mandatory follow-up endoscopy at 6 weeks after high-dose PPI therapy to exclude underlying malignancy or Barrett's esophagus 1, 4
- Take biopsy specimens to exclude underlying dysplasia 1
- Optimize lifestyle measures in addition to pharmacotherapy 3
- Consider laparoscopic fundoplication, magnetic sphincter augmentation, or transoral incisionless fundoplication in carefully selected patients 1
Endoscopic Documentation Requirements
Complete endoscopic evaluation must include 1:
- Erosive esophagitis graded according to LA classification when present
- Hill grade of diaphragmatic flap valve
- Axial hiatus hernia length
- Inspection for Barrett's esophagus with Prague classification and biopsy when present
Critical Limitations
The LA classification should NOT be used for non-GERD esophagitis including eosinophilic esophagitis, infectious esophagitis, medication-induced esophagitis, or Crohn's disease-related esophagitis 2. For eosinophilic esophagitis, use the Eosinophilic Esophagitis Endoscopic Reference System (EREFS) or Index for Severity of Eosinophilic Esophagitis (I-SEE) score instead 2.
Common Pitfalls
- Grade A has poor interobserver agreement and may not reliably distinguish from normal findings 5
- Endoscopists frequently fail to communicate the LA grade to pathologists when biopsies are obtained 6
- Standard white-light endoscopy may miss mucosal breaks; chromoendoscopy with Lugol's solution significantly improves detection and reduces misclassification 7
- The modified LA classification used in Japan (adding grades M and N for minimal changes) has poor interobserver agreement and is not recommended in Western guidelines 5, 8